On 1 May 2021 Epidyolex, the first medicinal cannabis drug product was listed on the Pharmaceutical Benefits...
May 6, 2021
1 min read
Healthcare
Sort by Latest
- Sort by Latest
- Sort by Views
First medicinal cannabis drug listed on the Australian Pharmaceuticals Benefits Scheme
EU merger control – new guidance brings uncertainty – particularly for tech and pharma acquisitions
Illumina’s acquisition of cancer testing startup, Grail, looks set to be the testing ground for the Commission’s...
April 20, 2021
7 min read
Singapore Gets Vaccinated! Introduction of the Pandemic Special Access Route (PSAR) for COVID-19 vaccines, therapeutic products and medical devices
As part of a slew of measures to mitigate the effect of the COVID-19 pandemic in Singapore,...
March 25, 2021
6 min read
Introduction of the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021
On the 3rd February 2021, the Narcotic Drugs Amendment (Medicinal Cannabis) Bill 2021 (Bill) was introduced...
March 2, 2021
1 min read
Impact of Brexit on Artificial Intelligence in Healthcare
AI developments in the UK
The UK is starting to uncover significant opportunities...
February 5, 2021
5 min read
Indirect infringement in Spanish courts: a trend reversal and some teachings concerning infringement of second use medical claims
The specialised Section No. 15 of the Appeal Court of Barcelona has recently clarified what indirect...
January 22, 2021
4 min read
Chinese patent linkage system – the Chinese Supreme Court issues Draft Judicial Interpretations
The Chinese Supreme Court (“SPC”) released on 29 October 2020 the “Provisions on Several...
November 13, 2020
6 min read
Managing Scientific Collaboration Agreements within the French Healthtech Sector
Scientific Collaboration Agreements allow a public servant, most of the time a researcher, (who...
November 9, 2020
5 min read
Australian Courts apply “European Support” test to find key Wyeth’s Prevnar 13 patent invalid
In the recent decision in the Australian front of the Prevnar 13 patent litigation, Merck...
November 4, 2020
10 min read
AstraZeneca held liable for additional healthcare costs
In a judgment of 14 October 2020 the District Court The Hague ruled in a landslide decision that AstraZeneca...
October 15, 2020
10 min read